Evra (norelgestromin;ethinyl estradiol)
- Region
- 🇪🇺 EU
- Active substance
- norelgestromin;ethinyl estradiol
- Company
- Gedeon Richter Plc.
- Status
- Authorised
- Therapeutic area
- Contraception
- EU approval
- Thu 22 Aug 2002
- Application
- EMEA/H/C/000410
- ATC
- G03AA13
- Official record
- www.ema.europa.eu
Indication
Female contraception. Evra is intended for women of fertile age. The safety and efficacy has been established in women aged 18 to 45 years.
Regulatory milestones
No milestones recorded in the last year.
Follow Evra
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.